Insight Molecular Diagnostics Inc. (IMDX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Insight Molecular Diagnostics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.55x | -0.51x | -0.69x | -0.49x | -3.01x | -5.23x |
| P/B Ratio | -7.26x | -2.53x | 0.93x | 0.90x | 2.96x | 4.67x |
| P/S Ratio | 56.37x | 16.54x | 12.73x | 37.13x | 87.79x | 128.69x |
| Profitability | ||||||
| Gross Margin | 4.7% | 39.3% | 27.5% | -1.9% | 64.6% | -52.5% |
| Operating Margin | -754.1% | -3245.1% | -1672.4% | -1878.6% | -2444.3% | -2443.3% |
| Net Margin | -1238.5% | -3225.0% | -1848.4% | -7609.8% | -2916.2% | -2461.5% |
| EBITDA Margin | -699.9% | -3137.4% | -1538.5% | -1389.2% | -2204.6% | -2511.5% |
| Liquidity | ||||||
| Current Ratio | 1.27x | 1.62x | 1.49x | 2.11x | 2.77x | 1.03x |
| Quick Ratio | 1.23x | 1.56x | 1.49x | 2.11x | 2.75x | 1.03x |
| Leverage | ||||||
| Debt/Equity | -0.11x | -0.30x | 0.14x | 0.09x | 0.09x | 0.26x |
YoY = year-over-year change. Source: FMP..